Ubs Group Ag Revolution Medicines, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 193,079 shares of RVMD stock, worth $10.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

193,079

Previous 217,763 11.34%

Holding current value

$10.9 Million

Previous $8.45 Million 3.51%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.92 - $47.94 $911,333 - $1.18 Million	-24,684 Reduced 11.34%	193,079 $8.75 Million
Q2 2024 Aug 13, 2024	SELL	$30.14 - $40.68 $2.63 Million - $3.55 Million	-87,216 Reduced 28.6%	217,763 $8.45 Million
Q1 2024 May 13, 2024	SELL	$26.56 - $33.55 $41,938 - $52,975	-1,579 Reduced 0.52%	304,979 $9.83 Million
Q4 2023 Feb 09, 2024	BUY	$18.35 - $34.12 $3.84 Million - $7.14 Million	209,399 Added 215.52%	306,558 $8.79 Million
Q3 2023 Nov 09, 2023	SELL	$25.17 - $35.05 $989,055 - $1.38 Million	-39,295 Reduced 28.8%	97,159 $2.69 Million
Q2 2023 Aug 11, 2023	SELL	$20.28 - $27.0 $38,673 - $51,489	-1,907 Reduced 1.38%	136,454 $3.65 Million
Q1 2023 May 12, 2023	SELL	$20.76 - $30.09 $607,894 - $881,095	-29,282 Reduced 17.47%	138,361 $3 Million
Q4 2022 Feb 08, 2023	BUY	$17.68 - $25.53 $2.39 Million - $3.45 Million	134,940 Added 412.62%	167,643 $3.99 Million
Q3 2022 Nov 10, 2022	SELL	$17.46 - $26.0 $145,424 - $216,554	-8,329 Reduced 20.3%	32,703 $645,000
Q2 2022 Aug 10, 2022	SELL	$14.54 - $27.17 $714,161 - $1.33 Million	-49,117 Reduced 54.48%	41,032 $800,000
Q1 2022 May 16, 2022	SELL	$17.31 - $26.4 $420,131 - $640,754	-24,271 Reduced 21.21%	90,149 $2.3 Million
Q4 2021 Feb 14, 2022	SELL	$24.35 - $33.7 $71,345 - $98,741	-2,930 Reduced 2.5%	114,420 $2.88 Million
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $2.78 Million - $3.88 Million	116,252 Added 10587.61%	117,350 $3.23 Million
Q2 2021 Aug 13, 2021	SELL	$29.0 - $47.44 $9,860 - $16,129	-340 Reduced 23.64%	1,098 $35,000
Q1 2021 May 12, 2021	BUY	$37.21 - $54.43 $8,744 - $12,791	235 Added 19.53%	1,438 $66,000
Q4 2020 Feb 11, 2021	BUY	$30.19 - $45.49 $36,318 - $54,724	1,203 New	1,203 $48,000
Q3 2020 Nov 12, 2020	SELL	$22.61 - $34.8 $110,608 - $170,241	-4,892 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$19.65 - $39.34 $68,362 - $136,863	-3,479 Reduced 41.56%	4,892 $154,000
Q1 2020 May 01, 2020	BUY	$20.0 - $34.08 $167,420 - $285,283	8,371 New	8,371 $183,000

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $4.95B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account